Braden Sydney & Clive van Breda

REVOLUTIONARY TUBERCULOSIS SCREENING TECHNOLOGY THAT DRASTICALLY IMPROVES ACCURACY AND REDUCES COSTS. This innovative solution empowers healthcare facilities with AI-powered diagnostic capabilities, reducing costs and getting patients the care they need faster. Beyond Tuberculosis, AI Diagnostics are pursuing a future where their SAHPRA-approved and ISO13485 Certified digital stethoscope and powerful AI models will be able to diagnose other cardio and pulmonary conditions, helping to overcome some of the world’s most pervasive and devastating diseases.